A comparison of methods used for the prevention of venous thromboembolic disease among orthopaedic surgeons at Wolverhampton, United Kingdom and Auckland, New Zealand.
University of Birmingham.
P
P
Bennett
D000925:Anticoagulants / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D048228:Intermittent Pneumatic Compression Devices; D009520:New Zealand; D019637:Orthopedic Procedures / Q000009:adverse effects* / Q000706:statistics & numerical data; D009985:Orthopedics; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D012307:Risk Factors; D053828:Stockings, Compression; D006113:United Kingdom; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin